The Miami Project to Cure Paralysis, Department of Neurological Surgery, University of Miami, 1400 NW 12th Ave, Miami, FL 33136, USA.
Mol Cell Neurosci. 2010 May;44(1):43-54. doi: 10.1016/j.mcn.2010.02.002. Epub 2010 Feb 14.
Neurons in the central nervous system lose their intrinsic capacity for axon regeneration as they mature, and it is widely hypothesized that changes in gene expression are responsible. Testing this hypothesis and identifying the relevant genes has been challenging because hundreds to thousands of genes are developmentally regulated in CNS neurons, but only a small subset are likely relevant to axon growth. Here we used automated high content analysis (HCA) methods to functionally test 743 plasmids encoding developmentally regulated genes in neurite outgrowth assays using postnatal cortical neurons. We identified both growth inhibitors (Ephexin, Aldolase A, Solute Carrier 2A3, and Chimerin), and growth enhancers (Doublecortin, Doublecortin-like, Kruppel-like Factor 6, and CaM-Kinase II gamma), some of which regulate established growth mechanisms like microtubule dynamics and small GTPase signaling. Interestingly, with only one exception the growth-suppressing genes were developmentally upregulated, and the growth-enhancing genes downregulated. These data provide important support for the hypothesis that developmental changes in gene expression control neurite outgrowth, and identify potential new gene targets to promote neurite outgrowth.
中枢神经系统中的神经元在成熟后失去了内在的轴突再生能力,人们广泛假设这与基因表达的变化有关。测试这一假设并确定相关基因一直具有挑战性,因为成百上千的基因在中枢神经系统神经元中受到发育调控,但只有一小部分可能与轴突生长有关。在这里,我们使用自动化高内涵分析 (HCA) 方法,在使用出生后皮质神经元的神经突生长测定中,对 743 个编码发育调控基因的质粒进行功能测试。我们鉴定了生长抑制剂(Ephexin、Aldolase A、Solute Carrier 2A3 和 Chimerin)和生长增强剂(Doublecortin、Doublecortin-like、Kruppel-like Factor 6 和 CaM-Kinase II gamma),其中一些调节已建立的生长机制,如微管动力学和小 GTPase 信号转导。有趣的是,除了一个例外,生长抑制基因在发育过程中上调,而生长增强基因下调。这些数据为基因表达的发育变化控制神经突生长的假设提供了重要支持,并确定了促进神经突生长的潜在新基因靶点。